| E-Folder |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Strategic Planning > Understanding Why Clients and Customers Leave |
|
E-Folder - Understanding Why Clients and Customers Leave
Why do those clients/customers/patients leave us; and how big is the percentage that we could possibly win back? Depending o According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product n the source, survey data varies slightly. In fact, is amazing how remarkably consistent the percentages are from survey to ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in survey. So, here’s why your clients/customers/patients leave: . 1% Die Nothing you can do about that. 9% Have left you lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. because they found a competitor they liked better. (Ouch!) Remember, your competitors are always looking for business. You here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe r customers are always targets for their new business marketing. This should become a priority to your company or firm to pre d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ent this from happening. 9% Moved away or outgrew the need for your product or service. Even B2B companies can have custome ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc rs relocate, change the nature of their business, or go under. 14% Leave you because they have complaints that were not reso easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi lved. Of course, you give great customer service, but what about all the people that come in contact with your clients? Do nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically you really know how all of them represent your company? It’s estimated that for every complaint you get, there are seven to and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ten you never hear about. 67% Say they leave because of no special reason they simply forget. They forget to come back beca ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi se you didn’t, or don’t remind them enough. Here is a group that is predisposed to do business with you, and is just waiting ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a for you to ask them to come back. Ignoring this group is hazardous to your profits. One of the biggest mistakes business o dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod wners make is not having a system in place that allows them to “help stay in touch” with their customers. Question: Do you cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin know the optimum number of times you should reach out and touch your clients or customers? Between 48 and 52 times in a year tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen , once a week, is the optimum level of customer contact. If your clients/customers/patients want less, they will tell you th t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel right number. When you do contact them that often, ensure every contact is not a sales pitch. Give them information they c ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust an use or enjoy, and don’t forget birthdays and anniversaries. How profitable are those customers? Retail analyst and autho y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products r, Paco Underhill’s research has determined “that a previous customer will spend on average twice as much as a first time cus . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de tomer.” There you have it. A big percentage of your inactive customers are just waiting for you to ask them to come back. elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip Going after those inactive clients and customers is a sure way to get a great Return on Investment for your marketing efforts tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Staff Retention - is It a Big Issue for Employers? Marketing with the Blindfold Off 11 Rules for Selling to a Skeptic
|